Chain drugstore industry leaders are warning Congress that, instead of improving patient knowledge about prescription drugs, overuse of FDA patient medication guides could have the opposite effect.
In a statement to the Senate Health, Education, Labor and Pensions Committee, the National Association of Chain Drug Stores (NACDS) expressed concern about proposals that "could lead to the unnecessary approval of MedGuides outside the scope of the FDA's original intention to require them only for a few products which pose a ‘serious or significant concern.'"
Already >1500 individual drug products must be dispensed with MedGuides. Arguing that FDA-required MedGuides may not be the most effective way to educate patients for all medications, NACDS said that these pamphlets "should remain a resource only for medications which pose a serious or significant concern."
The Oncology Care Pharmacist in Health-System Pharmacy
According to the National Cancer Institute, almost 40% of men and women will be given a diagnosis of some form of cancer in their lifetime.
News from the year's biggest meetings
Clinical features with downloadable PDFs